Political pressure on examiners is no way to reform India's patent system

Political pressure on examiners is no way to reform India's patent system

The battle over the Indian patent sought by Gilead Sciences for its Hepatitis C drug Sofosbuvir (branded Sovaldi) seemingly came to a conclusion last week when the country's patent office reversed course to grant the US drug maker protection for…

Unlock unlimited access to all IAM content